On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles

Acta Biomaterialia

Volumn 4, Issue 1, 2008, Pages 40-48

  Zhang, J ^a,b   Rana, S ^a,b   Srivastava, R S ^a   Misra, R D K ^a,b  

^a UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

^b University of Louisiana at Lafayette   (United States)

Author keywords

Drug delivery; Folic acid receptor; Functionalization; Magnetite nanoparticles

Indexed keywords

CHELATION; CONTROLLED DRUG DELIVERY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MAGNETITE; MAGNETITE NANOPARTICLES; NANOMAGNETICS; ORGANIC ACIDS; POLYETHYLENES; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

A-STABLE; ACID RECEPTORS; DOXORUBICIN; FOLATE RECEPTOR; FOLIC ACID RECEPTOR; FOLIC ACIDS; FUNCTIONALIZATIONS; FUNCTIONALIZED; FUNCTIONALIZED MAGNETITE NANOPARTICLES; IN-VITRO;

POLYETHYLENE GLYCOLS;

DOXORUBICIN; FOLIC ACID; MACROGOL; MAGNETITE; NANOPARTICLE;

ARTICLE; CONJUGATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IN VITRO STUDY; INFRARED SPECTROSCOPY; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS;

EID: 36248953236     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2007.06.006     Document Type: Article

References (52)

1. Gu H., Yu K., Yang Z., Chang C.K., and Yu B. Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles: a potential candidate for bimodal anticancer therapy. Chem Commun 34 (2005) 4270
2. Detty M.R., Gibson S.L., and Wagner S.J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 47 (2004) 3897
3. Jordan A., Scholz R., Wust P., Fahling H., and Felix R. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 201 (1999) 413
4. Orive G., Hernández R.M., Gascón A.R., Domínguez-Gil A., and Pedraz J.L. Drug delivery in biotechnology: present and future. Curr Opin Biotechnol 14 (2003) 659
5. Maaßen S., Fattal E., Muller R.H., et al. Cell cultures for the assessment of toxicity and uptake of polymeric particulate drug carriers. STP Pharma Sci 3 (1993) 11
6. Rokkannen P., Bostman O., Hirvensalo E., Makela E.A., Partio E.K., Patiala H., et al. Totally biodegradable implants for bone fixation and ligament repair. MRS Bull 25 (2000) 21
7. Li S.M., Garreau H., and Vert M. Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media. J Mater Sci Mat Med 1 (1990) 198
8. Jeong B., Bae Y.H., Lee D.S., and Kim S.W. Biodegradable block copolymers as injectable drug-delivery systems. Nature 388 (1997) 860
9. D'Souza A.J.M., Schowen R.L., and Topp E.-M. Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism. J Control Rel 94 (2004) 91
10. Silva G.A. Introduction to nanotechnology and its applications to medicine. Surg Neurol 61 (2004) 216
11. Mah C., Fraites T.J., Zolotukhin I., Song S., Flotte T., Dobson J., et al. Improved method of recombinant. Mol Ther 6 (2002) 106
12. Roy I.O., Tymish Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamictherapy. J Am Chem Soc 125 (2003) 7860
13. Lovat V., Pantarotto D., Lagostena L.B.C., Grandolfo M., Righi M., Spalluto G., et al. Carbon nanotube substrates boost neuronal electrical signaling. Nano Lett 5 (2005) 1107
14. Neuberger T.S., Bernhard H., Heinrich H., and Margarete V.R.B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293 (2005) 483
15. Pankhurst Q.A., Connolly J., Jones S.K., and Dobson J. Application of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 36 (2003) R167
16. Shinkai M. Functional magnetic particles for medical application. J Biosci Bioeng 94 (2002) 606
17. Erbe E.M., Marx J.G., Clineff T.D., and Bellincampi L.D. Potential of an ultraporous β-tricalcium phosphate synthetic cancellous bone void filler and bone marrow aspirate composite graft. Euro Spine J 10 (2001) 141
18. Vaz-Santiago J., Lule J., Rohrlich P., Kravtzoff R., Le Roy E., Davignon J.-L., et al. IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy. Cryotherapy 4 (2002) 11-19
19. Chouly C., Pouliquen D., Lucet I., Jeune P., and Pellet J.J. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 13 (1996) 245
20. Davis S.S. Biomedical applications of nanotechnology - implications for drug targeting and gene therapy. Trend Biotechnol 15 (1997) 217
21. Gaur U., Sahoo S.K., Dey T.K., Ghosh P.C., Maitra A., and Ghosh P.K. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 202 (2000) 1
22. Moghimi S.M., and Rajabi-Siahboomi A.R. Recent advances in cellular, sub-cellular and molecular targeting. Adv Drug Deliv Rev 41 (2000) 129
23. Hood J.D., Bednarski M., Frausto R., Guccione S., Reisfeld R.A., Xiang R., et al. Tumor regression by targeted gene delivery to the neovasculature. Science 296 (2002) 2404
24. Schoepf U., Marecos E., Melder R., Jian R., and Weissleder R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Bio Techniq 24 (1998) 642
25. Moore A., Basilion J.P., Chiocca E.A., and Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1402 (1998) 239
26. Weissleder R., Cheng H.C., Bogdanova A., and Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 7 (1997) 258
27. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R., et al. Distribution of the folate receptor Gp38 in normal and malignant-cell lines and tissues. Cancer Res 52 (1992) 3396
28. Antony A.C. Folate receptors. Ann Rev Nutr 16 (1996) 501
29. Lu Y., and Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 54 (2002) 675
30. Maziarz K.M., Monaco H.L., Shen F., and Ratnam M. Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta. J Biolog Chem 274 (1999) 11086
31. Aronov O., Horowitz A.T., Gabizon A., and Gibson D. Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies. Bioconjug Chem 14 (2003) 563
32. Choi H., Choi S.R., Zhou R., Kung H.F., and Weichen I. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11 (2004) 996
33. Sun C., Sze R., and Zhang M.Q. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res Part A 78A (2006) 550
34. Rana S., Gallo A., Srivastava R.S., and Misra R.D.K. On the suitability of nanocrystalline ferrites as magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics. Acta Biomater 3 (2007) 233
35. Zhang J., Srivastava R.S., and Misra R.D.K. Core-shell magnetic nanoparticles encapsulated with smart stimuli-responsive polymer: synthesis, characterization, and LCST of viable drug-targeting delivery system. Langmuir 23 (2007) 6342
36. 4 (M{double bond, long}Fe, Co, Mn) nanoparticles. J Am Chem Soc 126 (2004) 273
37. Berry L.G., and Thompson R.M. X-ray diffraction data for minerals (1962), Waverly Press, Baltimore, MD p. 194
38. Yamaura M., Camilo R.L., Sampaio L.C., Macedo M.A., Nakamura M., and Toma H.E. Preparation and characterization of (3-aminopropyl) triethoxysilane-coated magnetic nanoparticles. J Mag Magn Mater 279 (2004) 210
39. Ma M., Zhang Y., Yu W., Shen H.Y., Zhang H.Q., and Gu N. Colloids and Surfaces A. Physicochem Eng Aspects 212 (2003) 219
40. Zhang Y., Kohler N., and Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomater 23 (2002) 1553
41. Henry C.M. Drug delivery - materials scientists look for new materials and ways to manipulate existing ones in order to fulfill unmet needs. Chem Eng News 80 (2002) 39
42. Hans M.L., and Lowman A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6 (2002) 319
43. Sopimath K.S., Aminabhavi T.M., and Kulkarni A.R. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Rel 70 (2001) 1
44. Gupta A.K., and Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanosci 3 (2004) 66
45. Yoo H.S., and Park T.G. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Rel 100 (2004) 247
46. Edelman E.R., Fiorino A., Grodzinsky A., and Langer R. Mechanical deformation of polymer matrix controlled release devices modulates drug release. J Biomed Mater Res 26 (1992) 1619
47. Sershen S., and West J. Implantable, polymeric systems for modulated drug delivery. Adv Drug Deliv Rev 54 (2002) 1225
48. Paoli V.M.D., Lacerda S.H.D.P., Spinu L., Ingber B., Rosenzweig Z., and Rosenzweig N. Effect of an oscillating magnetic field on the release properties of magnetic collagen gels. Langmuir 22 (2006) 5894
49. Polischuk A.Y., Zaikov G.E., and Petropoulos J.H. The modeling of the simultaneous transport of solvent and low-molecular compounds in swelling polymers. Inter J Polym Mater 19 (1993) 1
50. Siepmann J., Podual K., Sriwongjanya M., Peppas N.A., and Bodmeier R. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J Pharm Sci 88 (1999) 65
51. Tzafriri A.R. Mathematical modeling of diffusion-mediated release from bulk degrading matrices. J Control Rel 63 (2000) 69
52. Siepmann F., Muschert S., Flament M.P., Leterme P., Gayot A., and Siepmann J. Controlled drug release from Gelucire-based matrix pellets: experiment and theory. Int J Pharmaceutics 317 (2006) 136